Clinical Trials

AGCT1532: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients with Intermediate and Poor-Risk Metastatic Germ Cell Tumours (CTMS# 18-0123)

Cancer Type

Germ Cell Tumors of the CNS

ClinicalTrials.gov Identifier

NCT02582697

Principal Investigator

Anne–Marie Langevin MD

For more information about this study
View Details

About This Study

The purpose of this study is to determine whether accelerated BEP chemotherapy is more effective than standard BEP chemotherapy in males with intermediate and poor-risk metastatic germ cell tumours.